Latest filing published 22 May 2024 for Zoetis Inc., €86k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -4.2%Entry US$6.15 · Close at T+365 US$5.89
- +74.4%Entry US$4.14 · Close at T+365 US$7.22
- +43.6%Entry US$3.19 · Close at T+365 US$4.58
- +57.4%Entry US$3.19 · Close at T+365 US$5.02
- +145.0%Entry US$3.18 · Close at T+365 US$7.79
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Linda Rhodes: trading record in brief
Filings by Linda Rhodes span 3 companies, the busiest being Zoetis Inc., Immucell Corp and Aratana Therapeutics, Inc. Over a trading history stretching from 19 June 2007 to 21 May 2024, the count stands at 36 filings.
Market trades split into 10 purchases (€19k) and 8 sales (€1.1M). Taken together, the sales exceed the purchases by €1.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 9 option exercises.
Half of the purchases are above €378 and half below. Ninety days after publication, 10 purchases show a median change of +3.3%, with the price up in 70% of them. These figures describe past trades and do not predict future prices.
Most recently, on 22 May 2024, the filings show a transaction worth €86k in Zoetis Inc. The latest purchase dates back some time: it was published 3,934 days ago, on 1 February 2016. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Linda Rhodes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 541 shares@ US$172.7912.6% of flowCommon StockSEC:0001555280-24-000254:1
- 2,441 sharesCommon StockSEC:0001555280-24-000254:0
- 322 shares@ US$197.328.6% of flowCommon StockSEC:0001555280-24-000175:1
- 1,463 sharesCommon StockSEC:0001555280-24-000175:0
- 329 shares@ US$195.758.7% of flowCommon StockSEC:0001555280-24-000124:1
- 1,493 sharesCommon StockSEC:0001555280-24-000124:0
- 358 shares@ US$158.337.7% of flowCommon StockSEC:0001555280-23-000105:1
- 1,626 sharesCommon StockSEC:0001555280-23-000105:0
- 589 shares@ US$198.8715.0% of flowCommon StockSEC:0001555280-22-000108:1
- 2,673 sharesCommon StockSEC:0001555280-22-000108:0
- 612 shares@ US$166.7125.9% of flowCommon StockSEC:0001555280-21-000127:1
- 2,779 sharesCommon StockSEC:0001555280-21-000127:0
- 1,087 shares@ US$159.1660.7% of flowCommon StockSEC:0001555280-20-000273:0
- 720 shares@ US$154.5139.3% of flowCommon StockSEC:0001555280-20-000251:1
- 3,270 sharesCommon StockSEC:0001555280-20-000251:0
- 1,009 shares@ US$6.3229.4% of flowCommon Stock, par value $0.10 shareSEC:0001547522-16-000244:0
- 2,857 shares@ US$5.25100.0% of flowCommon Stock, par value $0.10 per shareSEC:0001547522-16-000204:0Canonical exit: 28 Apr 2016 (T+90)
- 17,200 shares0Common StockSEC:0001209191-15-036748:0
- 11,700 shares@ US$14.78Common StockSEC:0001209191-15-036748:1
- 3,300 shares@ US$15.78Common StockSEC:0001209191-15-036748:2
- 20,000 shares@ US$20.00Common StockSEC:0001209191-15-023727:0
- 10,000 shares@ US$18.00Common StockSEC:0001181431-14-039550:0
- 4,700 shares@ US$6.00Common StockSEC:0001181431-14-034049:0
- 10,000 shares@ US$16.00Common StockSEC:0001181431-14-026243:0
- 4,626 shares@ US$15.00Common StockSEC:0001181431-14-024284:0
25 of 36 declarations
